Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hemorrhoidal pathology describes the symptomatic enlargement, inflammation, prolapse, or thrombosis of the anal vascular cushions (hemorrhoidal plexus), presenting as pain, bleeding, prolapse, or anal discomfort. The underlying tissue consists of vascular, connective, and smooth muscle elements, but there is no single molecular or receptor target. Treatments focus on symptom management, vascular modulation, and, if required, physical ablation of the tissue.
Drug interventions do not target a single molecule; they act broadly: Improvement of venous tone (phlebotonics), local anesthesia (topical anesthetics), anti-inflammatory effect (NSAIDs and corticosteroid creams), fibrosis induction (sclerotherapy), and mechanical occlusion and vascular disruption (rubber band ligation, surgical excision).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hemorrhoidal Pathology.